A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of VT-1161 oral capsules in the treatment of subjects with recurrent vulvovaginal candidiasis
Cumulative live birth rate of patients at high risk of ohss after freeze-all embryos at cleavage or blastocyst stage in a single embryo transfer setting
SPIRIT EXTENSION: An international phase 3 open-label, single-arm, safety and efficacy extension study to evaluate relugolix co-administered with low-dose estradiol and norethindrone acetate in women with endometriosis-associated pain
Prospective multicentre non-interventional study to assess the patterns of use of rekovelle in women undergoing in vitro fertilisation or intracytoplasmic sperm injection procedures in routine clinical practice
LIBERTY 2: An international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate relugolix co administered with and without low-dose estradiol and norethindrone acetate in women with heavy menstrual bleeding associated with uterine fibroids
An international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate relugolix administered with and without low-dose estradiol and norethindrone acetate in women with endometriosis-associated pain
Utilisation des techniques de biologie moléculaire pour améliorer la sensibilité de la détection de cellules néoplasiques au sein du tissu ovarien cryopréservé pour préservation de la fertilité avant chimiothérapie
A randomised, double-blind, parallel group, placebo-controlled multicentre phase 3 study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed definitive local treatment and neoadjuvant or adjuvant chemotherapy (OLYMPIA Study)
An international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate relugolix co-administered with and without low dose estradiol and norethindrone actetate in women with heavy menstrual bleeding associated with uterine fibroids (LIBERTY 2)
SOFIA: Safety of OVALEAP ® (follitropin alfa) in infertile women undergoing superovulation for assisted reproductive technologies. A multi-national, comparative, prospective, non-Interventional, observational cohort study
KYSS - Kyleena Satisfaction Study / Observational study on user satisfaction with the levonorgestrel intrauterine delivery system Kyleena (LNG-IUS 12) in new contraceptive users and after switching from another contraceptive method
A phase 3, double-blind, randomized, placebo-controlled study to assess the safety and efficacy of a single oral administration of nolasiban to improve pregnancy rates following IVF or ICSI in Day 3 and Day 5 fresh embryo transfer cycles